Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
It is hypothesized that repository corticotropin injection in combination with other biologic
agents will be able to provide relief of both rheumatoid arthritis and acute exacerbations of
rheumatoid arthritis for patients with disease that had inadequately responded to biologics
previously.